Newer hypolipidemic compounds.
D000818:Animals; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary; D002994:Clofibrate / Q000031:analogs & derivatives / Q000494:pharmacology; D006218:Halofenate / Q000494:pharmacology; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D011341:Probucol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood
D002791:Cholesterol, Dietary; D000960:Hypolipidemic Agents; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D002994:Clofibrate; D006218:Halofenate; D011341:Probucol